| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
783 |
735 |
$108K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
10,601 |
2,295 |
$100K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
674 |
627 |
$98K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,455 |
1,075 |
$77K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
289 |
257 |
$43K |
| G0378 |
Hospital observation service, per hour |
14 |
14 |
$30K |
| 36415 |
Collection of venous blood by venipuncture |
3,420 |
1,190 |
$24K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
277 |
215 |
$16K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
956 |
918 |
$15K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,098 |
811 |
$12K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
2,734 |
860 |
$11K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
10,953 |
3,143 |
$8K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
40 |
37 |
$8K |
| 71045 |
Radiologic examination, chest; single view |
1,314 |
622 |
$8K |
| 80053 |
Comprehensive metabolic panel |
3,685 |
1,610 |
$7K |
| 83735 |
|
6,994 |
1,710 |
$5K |
| 70450 |
Computed tomography, head or brain; without contrast material |
46 |
42 |
$5K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
141 |
136 |
$4K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
858 |
201 |
$4K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
3,219 |
1,796 |
$3K |
| 82248 |
|
1,841 |
1,020 |
$3K |
| 0001A |
|
96 |
90 |
$3K |
| 81001 |
|
980 |
750 |
$3K |
| 82803 |
|
1,418 |
644 |
$3K |
| 0002A |
|
92 |
87 |
$3K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
111 |
107 |
$2K |
| 84484 |
|
1,860 |
900 |
$2K |
| 84100 |
|
4,108 |
890 |
$2K |
| 99442 |
|
165 |
151 |
$2K |
| 71046 |
Radiologic examination, chest; 2 views |
422 |
399 |
$2K |
| 86850 |
|
719 |
404 |
$1K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
12 |
12 |
$1K |
| 86901 |
|
747 |
420 |
$1K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
13 |
13 |
$1K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
83 |
75 |
$1K |
| 82247 |
|
348 |
174 |
$923.10 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
124 |
96 |
$766.19 |
| 86900 |
|
747 |
420 |
$714.21 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
28 |
27 |
$710.38 |
| 83605 |
|
1,341 |
718 |
$578.03 |
| 82374 |
|
660 |
536 |
$556.76 |
| 85027 |
|
2,063 |
668 |
$547.20 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
17 |
15 |
$545.04 |
| 82565 |
|
721 |
570 |
$489.77 |
| 81025 |
|
49 |
47 |
$454.20 |
| J3490 |
Unclassified drugs |
105 |
72 |
$396.04 |
| 83690 |
|
444 |
369 |
$391.77 |
| 82947 |
|
778 |
586 |
$372.25 |
| 84295 |
|
773 |
584 |
$334.02 |
| 84520 |
|
710 |
568 |
$326.04 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
30 |
30 |
$285.20 |
| 85610 |
|
2,955 |
865 |
$248.27 |
| 84132 |
|
567 |
459 |
$242.88 |
| 83880 |
|
144 |
95 |
$178.92 |
| 82330 |
|
224 |
171 |
$166.34 |
| 87040 |
|
357 |
120 |
$153.37 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
406 |
56 |
$129.90 |
| 84460 |
|
308 |
159 |
$128.16 |
| 82310 |
|
90 |
83 |
$126.94 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
244 |
189 |
$120.45 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
15 |
14 |
$97.00 |
| 85014 |
|
333 |
239 |
$95.96 |
| 84075 |
|
310 |
160 |
$95.34 |
| 84450 |
|
251 |
119 |
$94.84 |
| 84145 |
|
420 |
241 |
$94.63 |
| 97162 |
|
72 |
65 |
$81.81 |
| 85730 |
|
1,476 |
338 |
$70.83 |
| 82435 |
|
120 |
69 |
$49.22 |
| 84443 |
Thyroid stimulating hormone (TSH) |
99 |
89 |
$28.40 |
| 81003 |
|
61 |
55 |
$23.58 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
12 |
12 |
$12.69 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
16 |
12 |
$5.99 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
479 |
257 |
$0.18 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
65 |
59 |
$0.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
65 |
59 |
$0.00 |
| 91300 |
|
140 |
119 |
$0.00 |
| 87186 |
|
17 |
12 |
$0.00 |
| 97116 |
|
35 |
12 |
$0.00 |
| 87205 |
|
19 |
13 |
$0.00 |
| 87070 |
|
16 |
12 |
$0.00 |